Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma
Background and Aim It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been con...
Gespeichert in:
Veröffentlicht in: | Journal of gastroenterology and hepatology 2015-05, Vol.30 (5), p.925-932 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 932 |
---|---|
container_issue | 5 |
container_start_page | 925 |
container_title | Journal of gastroenterology and hepatology |
container_volume | 30 |
creator | Qu, Kai Yan, Zhaoyong Wu, Yousheng Chen, Yibing Qu, Ping Xu, Xinsen Yuan, Peng Huang, Xiaojun Xing, Jinliang Zhang, Hongxin Liu, Chang Zhang, Jing |
description | Background and Aim
It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been concerned.
Methods
Serum levels of alanine aminotransferase, aspartate aminotransferase, and albumin were used to detect liver injury. Hepatic artery ligation was performed in carbon tetrachloride‐induced rat hepatic fibrosis model to mimic the effect of hepatic hypoxia on liver fibrosis after TACE. Sirius Red staining and immunohistochemical analysis of alpha‐smooth muscle actin (α‐SMA) were used to detect the activation of hepatic stellate cells. Moreover, the expression of hypoxia and fibrosis‐related molecules were analyzed at protein and/or mRNA level.
Results
Patients showed a significant increase in alanine aminotransferase and aspartate aminotransferase (P = 0.006), accompanied by a decrease in albumin (P = 0.005) after repeated TACE. Hepatic artery ligation significantly promoted carbon tetrachloride‐induced rat liver fibrosis progression as indicated by Sirius Red and α‐SMA staining, as well as increased expression of hypoxia‐inducible factor (HIF)‐1α, transforming growth factor (TGF)‐β1, and vascular endothelial growth factor (VEGF). Conditioned media of hypoxia‐treated L02 cells induced the expression of Collagen I and α‐SMA in LX‐2 cells, which was inhibited by HIF‐1α small interfering RNA. Finally, HIF‐1α inhibitor LW6 attenuated the hypoxia‐induced fibrosis progression in vivo.
Conclusion
Our data demonstrate that TACE‐induced hepatic hypoxia aggravates the fibrosis progression in peritumoral liver tissue, thus leads to the deterioration of liver function. Intervention of HIF‐1α might be a valuable strategy to optimize the efficacy and reduce the complication of TACE. |
doi_str_mv | 10.1111/jgh.12873 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1673074857</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1673074857</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3633-60a855b82e625567e3ced00d267cb1818ae6e1ae5c9fe5388b52c2402f000a873</originalsourceid><addsrcrecordid>eNp1kMFu1DAQhi0EokvhwAsgH-GQ1o5jO3uEquxCq3Ip6tGaOJONSxIHO2m7PATvwovwTHi7bW_MZTTSN79mPkLecnbEUx1fb9ojnpdaPCMLXhQs47pQz8mClVxmS8GXB-RVjNeMsYJp-ZIc5FIVXGi9IL8vAwwRwoTBQUdti73HvvKd-wWT8wOFzSbADUxY0zEx09z7kMDGVcFHF-mNA9puR3_nIHNDPVtXdUgbsJMPGf_7h9Y44lDjMNERpvYWttQNtMU0eItdN3cQqIVg3eB7eE1eNNBFfPPQD8n3z6eXJ-vs_Nvqy8nH88wKJUSmGJRSVmWOKpdSaRQWa8bqXGlb8ZKXgAo5oLTLBqUoy0rmNi9Y3iQHkEQdkvf73DH4nzPGyfQu7s6BAf0cDVdaMF2Ucod-2KM2PRwDNmYMroewNZyZnX6T9Jt7_Yl99xA7Vz3WT-Sj7wQc74Fb1-H2_0nm62r9GJntN1yc8O5pA8IPk27U0lxdrMzFap1fnalPZiX-Ad7Womk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1673074857</pqid></control><display><type>article</type><title>Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Qu, Kai ; Yan, Zhaoyong ; Wu, Yousheng ; Chen, Yibing ; Qu, Ping ; Xu, Xinsen ; Yuan, Peng ; Huang, Xiaojun ; Xing, Jinliang ; Zhang, Hongxin ; Liu, Chang ; Zhang, Jing</creator><creatorcontrib>Qu, Kai ; Yan, Zhaoyong ; Wu, Yousheng ; Chen, Yibing ; Qu, Ping ; Xu, Xinsen ; Yuan, Peng ; Huang, Xiaojun ; Xing, Jinliang ; Zhang, Hongxin ; Liu, Chang ; Zhang, Jing</creatorcontrib><description>Background and Aim
It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been concerned.
Methods
Serum levels of alanine aminotransferase, aspartate aminotransferase, and albumin were used to detect liver injury. Hepatic artery ligation was performed in carbon tetrachloride‐induced rat hepatic fibrosis model to mimic the effect of hepatic hypoxia on liver fibrosis after TACE. Sirius Red staining and immunohistochemical analysis of alpha‐smooth muscle actin (α‐SMA) were used to detect the activation of hepatic stellate cells. Moreover, the expression of hypoxia and fibrosis‐related molecules were analyzed at protein and/or mRNA level.
Results
Patients showed a significant increase in alanine aminotransferase and aspartate aminotransferase (P = 0.006), accompanied by a decrease in albumin (P = 0.005) after repeated TACE. Hepatic artery ligation significantly promoted carbon tetrachloride‐induced rat liver fibrosis progression as indicated by Sirius Red and α‐SMA staining, as well as increased expression of hypoxia‐inducible factor (HIF)‐1α, transforming growth factor (TGF)‐β1, and vascular endothelial growth factor (VEGF). Conditioned media of hypoxia‐treated L02 cells induced the expression of Collagen I and α‐SMA in LX‐2 cells, which was inhibited by HIF‐1α small interfering RNA. Finally, HIF‐1α inhibitor LW6 attenuated the hypoxia‐induced fibrosis progression in vivo.
Conclusion
Our data demonstrate that TACE‐induced hepatic hypoxia aggravates the fibrosis progression in peritumoral liver tissue, thus leads to the deterioration of liver function. Intervention of HIF‐1α might be a valuable strategy to optimize the efficacy and reduce the complication of TACE.</description><identifier>ISSN: 0815-9319</identifier><identifier>EISSN: 1440-1746</identifier><identifier>DOI: 10.1111/jgh.12873</identifier><identifier>PMID: 25641377</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Adult ; Aged ; Animals ; Carcinoma, Hepatocellular - drug therapy ; Carcinoma, Hepatocellular - pathology ; Cell Hypoxia ; Chemoembolization, Therapeutic - adverse effects ; Disease Models, Animal ; Disease Progression ; Epirubicin - administration & dosage ; Epirubicin - adverse effects ; Female ; Fibrosis ; Fluorouracil - administration & dosage ; Fluorouracil - adverse effects ; hepatocellular carcinoma ; Humans ; hypoxia ; Hypoxia-Inducible Factor 1, alpha Subunit - physiology ; Infusions, Intra-Arterial ; Liver - pathology ; Liver Cirrhosis, Experimental ; liver fibrosis ; Liver Neoplasms - drug therapy ; Liver Neoplasms - pathology ; Male ; Middle Aged ; Organoplatinum Compounds - administration & dosage ; Organoplatinum Compounds - adverse effects ; Rats, Sprague-Dawley ; transarterial chemoembolization</subject><ispartof>Journal of gastroenterology and hepatology, 2015-05, Vol.30 (5), p.925-932</ispartof><rights>2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd</rights><rights>2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3633-60a855b82e625567e3ced00d267cb1818ae6e1ae5c9fe5388b52c2402f000a873</citedby><cites>FETCH-LOGICAL-c3633-60a855b82e625567e3ced00d267cb1818ae6e1ae5c9fe5388b52c2402f000a873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjgh.12873$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjgh.12873$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25641377$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Qu, Kai</creatorcontrib><creatorcontrib>Yan, Zhaoyong</creatorcontrib><creatorcontrib>Wu, Yousheng</creatorcontrib><creatorcontrib>Chen, Yibing</creatorcontrib><creatorcontrib>Qu, Ping</creatorcontrib><creatorcontrib>Xu, Xinsen</creatorcontrib><creatorcontrib>Yuan, Peng</creatorcontrib><creatorcontrib>Huang, Xiaojun</creatorcontrib><creatorcontrib>Xing, Jinliang</creatorcontrib><creatorcontrib>Zhang, Hongxin</creatorcontrib><creatorcontrib>Liu, Chang</creatorcontrib><creatorcontrib>Zhang, Jing</creatorcontrib><title>Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma</title><title>Journal of gastroenterology and hepatology</title><addtitle>J Gastroenterol Hepatol</addtitle><description>Background and Aim
It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been concerned.
Methods
Serum levels of alanine aminotransferase, aspartate aminotransferase, and albumin were used to detect liver injury. Hepatic artery ligation was performed in carbon tetrachloride‐induced rat hepatic fibrosis model to mimic the effect of hepatic hypoxia on liver fibrosis after TACE. Sirius Red staining and immunohistochemical analysis of alpha‐smooth muscle actin (α‐SMA) were used to detect the activation of hepatic stellate cells. Moreover, the expression of hypoxia and fibrosis‐related molecules were analyzed at protein and/or mRNA level.
Results
Patients showed a significant increase in alanine aminotransferase and aspartate aminotransferase (P = 0.006), accompanied by a decrease in albumin (P = 0.005) after repeated TACE. Hepatic artery ligation significantly promoted carbon tetrachloride‐induced rat liver fibrosis progression as indicated by Sirius Red and α‐SMA staining, as well as increased expression of hypoxia‐inducible factor (HIF)‐1α, transforming growth factor (TGF)‐β1, and vascular endothelial growth factor (VEGF). Conditioned media of hypoxia‐treated L02 cells induced the expression of Collagen I and α‐SMA in LX‐2 cells, which was inhibited by HIF‐1α small interfering RNA. Finally, HIF‐1α inhibitor LW6 attenuated the hypoxia‐induced fibrosis progression in vivo.
Conclusion
Our data demonstrate that TACE‐induced hepatic hypoxia aggravates the fibrosis progression in peritumoral liver tissue, thus leads to the deterioration of liver function. Intervention of HIF‐1α might be a valuable strategy to optimize the efficacy and reduce the complication of TACE.</description><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Carcinoma, Hepatocellular - drug therapy</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Cell Hypoxia</subject><subject>Chemoembolization, Therapeutic - adverse effects</subject><subject>Disease Models, Animal</subject><subject>Disease Progression</subject><subject>Epirubicin - administration & dosage</subject><subject>Epirubicin - adverse effects</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Fluorouracil - administration & dosage</subject><subject>Fluorouracil - adverse effects</subject><subject>hepatocellular carcinoma</subject><subject>Humans</subject><subject>hypoxia</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - physiology</subject><subject>Infusions, Intra-Arterial</subject><subject>Liver - pathology</subject><subject>Liver Cirrhosis, Experimental</subject><subject>liver fibrosis</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Liver Neoplasms - pathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Organoplatinum Compounds - administration & dosage</subject><subject>Organoplatinum Compounds - adverse effects</subject><subject>Rats, Sprague-Dawley</subject><subject>transarterial chemoembolization</subject><issn>0815-9319</issn><issn>1440-1746</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMFu1DAQhi0EokvhwAsgH-GQ1o5jO3uEquxCq3Ip6tGaOJONSxIHO2m7PATvwovwTHi7bW_MZTTSN79mPkLecnbEUx1fb9ojnpdaPCMLXhQs47pQz8mClVxmS8GXB-RVjNeMsYJp-ZIc5FIVXGi9IL8vAwwRwoTBQUdti73HvvKd-wWT8wOFzSbADUxY0zEx09z7kMDGVcFHF-mNA9puR3_nIHNDPVtXdUgbsJMPGf_7h9Y44lDjMNERpvYWttQNtMU0eItdN3cQqIVg3eB7eE1eNNBFfPPQD8n3z6eXJ-vs_Nvqy8nH88wKJUSmGJRSVmWOKpdSaRQWa8bqXGlb8ZKXgAo5oLTLBqUoy0rmNi9Y3iQHkEQdkvf73DH4nzPGyfQu7s6BAf0cDVdaMF2Ucod-2KM2PRwDNmYMroewNZyZnX6T9Jt7_Yl99xA7Vz3WT-Sj7wQc74Fb1-H2_0nm62r9GJntN1yc8O5pA8IPk27U0lxdrMzFap1fnalPZiX-Ad7Womk</recordid><startdate>201505</startdate><enddate>201505</enddate><creator>Qu, Kai</creator><creator>Yan, Zhaoyong</creator><creator>Wu, Yousheng</creator><creator>Chen, Yibing</creator><creator>Qu, Ping</creator><creator>Xu, Xinsen</creator><creator>Yuan, Peng</creator><creator>Huang, Xiaojun</creator><creator>Xing, Jinliang</creator><creator>Zhang, Hongxin</creator><creator>Liu, Chang</creator><creator>Zhang, Jing</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201505</creationdate><title>Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma</title><author>Qu, Kai ; Yan, Zhaoyong ; Wu, Yousheng ; Chen, Yibing ; Qu, Ping ; Xu, Xinsen ; Yuan, Peng ; Huang, Xiaojun ; Xing, Jinliang ; Zhang, Hongxin ; Liu, Chang ; Zhang, Jing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3633-60a855b82e625567e3ced00d267cb1818ae6e1ae5c9fe5388b52c2402f000a873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Carcinoma, Hepatocellular - drug therapy</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Cell Hypoxia</topic><topic>Chemoembolization, Therapeutic - adverse effects</topic><topic>Disease Models, Animal</topic><topic>Disease Progression</topic><topic>Epirubicin - administration & dosage</topic><topic>Epirubicin - adverse effects</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Fluorouracil - administration & dosage</topic><topic>Fluorouracil - adverse effects</topic><topic>hepatocellular carcinoma</topic><topic>Humans</topic><topic>hypoxia</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - physiology</topic><topic>Infusions, Intra-Arterial</topic><topic>Liver - pathology</topic><topic>Liver Cirrhosis, Experimental</topic><topic>liver fibrosis</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Liver Neoplasms - pathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Organoplatinum Compounds - administration & dosage</topic><topic>Organoplatinum Compounds - adverse effects</topic><topic>Rats, Sprague-Dawley</topic><topic>transarterial chemoembolization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qu, Kai</creatorcontrib><creatorcontrib>Yan, Zhaoyong</creatorcontrib><creatorcontrib>Wu, Yousheng</creatorcontrib><creatorcontrib>Chen, Yibing</creatorcontrib><creatorcontrib>Qu, Ping</creatorcontrib><creatorcontrib>Xu, Xinsen</creatorcontrib><creatorcontrib>Yuan, Peng</creatorcontrib><creatorcontrib>Huang, Xiaojun</creatorcontrib><creatorcontrib>Xing, Jinliang</creatorcontrib><creatorcontrib>Zhang, Hongxin</creatorcontrib><creatorcontrib>Liu, Chang</creatorcontrib><creatorcontrib>Zhang, Jing</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qu, Kai</au><au>Yan, Zhaoyong</au><au>Wu, Yousheng</au><au>Chen, Yibing</au><au>Qu, Ping</au><au>Xu, Xinsen</au><au>Yuan, Peng</au><au>Huang, Xiaojun</au><au>Xing, Jinliang</au><au>Zhang, Hongxin</au><au>Liu, Chang</au><au>Zhang, Jing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma</atitle><jtitle>Journal of gastroenterology and hepatology</jtitle><addtitle>J Gastroenterol Hepatol</addtitle><date>2015-05</date><risdate>2015</risdate><volume>30</volume><issue>5</issue><spage>925</spage><epage>932</epage><pages>925-932</pages><issn>0815-9319</issn><eissn>1440-1746</eissn><abstract>Background and Aim
It was commonly accepted that chemotherapeutic cytotoxicity was the main cause for hepatic failure in hepatocellular carcinoma patients after repeated transarterial chemoembolization (TACE). However, the effect of embolization‐induced hypoxia on liver cirrhosis has rarely been concerned.
Methods
Serum levels of alanine aminotransferase, aspartate aminotransferase, and albumin were used to detect liver injury. Hepatic artery ligation was performed in carbon tetrachloride‐induced rat hepatic fibrosis model to mimic the effect of hepatic hypoxia on liver fibrosis after TACE. Sirius Red staining and immunohistochemical analysis of alpha‐smooth muscle actin (α‐SMA) were used to detect the activation of hepatic stellate cells. Moreover, the expression of hypoxia and fibrosis‐related molecules were analyzed at protein and/or mRNA level.
Results
Patients showed a significant increase in alanine aminotransferase and aspartate aminotransferase (P = 0.006), accompanied by a decrease in albumin (P = 0.005) after repeated TACE. Hepatic artery ligation significantly promoted carbon tetrachloride‐induced rat liver fibrosis progression as indicated by Sirius Red and α‐SMA staining, as well as increased expression of hypoxia‐inducible factor (HIF)‐1α, transforming growth factor (TGF)‐β1, and vascular endothelial growth factor (VEGF). Conditioned media of hypoxia‐treated L02 cells induced the expression of Collagen I and α‐SMA in LX‐2 cells, which was inhibited by HIF‐1α small interfering RNA. Finally, HIF‐1α inhibitor LW6 attenuated the hypoxia‐induced fibrosis progression in vivo.
Conclusion
Our data demonstrate that TACE‐induced hepatic hypoxia aggravates the fibrosis progression in peritumoral liver tissue, thus leads to the deterioration of liver function. Intervention of HIF‐1α might be a valuable strategy to optimize the efficacy and reduce the complication of TACE.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>25641377</pmid><doi>10.1111/jgh.12873</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0815-9319 |
ispartof | Journal of gastroenterology and hepatology, 2015-05, Vol.30 (5), p.925-932 |
issn | 0815-9319 1440-1746 |
language | eng |
recordid | cdi_proquest_miscellaneous_1673074857 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult Aged Animals Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - pathology Cell Hypoxia Chemoembolization, Therapeutic - adverse effects Disease Models, Animal Disease Progression Epirubicin - administration & dosage Epirubicin - adverse effects Female Fibrosis Fluorouracil - administration & dosage Fluorouracil - adverse effects hepatocellular carcinoma Humans hypoxia Hypoxia-Inducible Factor 1, alpha Subunit - physiology Infusions, Intra-Arterial Liver - pathology Liver Cirrhosis, Experimental liver fibrosis Liver Neoplasms - drug therapy Liver Neoplasms - pathology Male Middle Aged Organoplatinum Compounds - administration & dosage Organoplatinum Compounds - adverse effects Rats, Sprague-Dawley transarterial chemoembolization |
title | Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A29%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transarterial%20chemoembolization%20aggravated%20peritumoral%20fibrosis%20via%20hypoxia-inducible%20factor-1%CE%B1%20dependent%20pathway%20in%20hepatocellular%20carcinoma&rft.jtitle=Journal%20of%20gastroenterology%20and%20hepatology&rft.au=Qu,%20Kai&rft.date=2015-05&rft.volume=30&rft.issue=5&rft.spage=925&rft.epage=932&rft.pages=925-932&rft.issn=0815-9319&rft.eissn=1440-1746&rft_id=info:doi/10.1111/jgh.12873&rft_dat=%3Cproquest_cross%3E1673074857%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1673074857&rft_id=info:pmid/25641377&rfr_iscdi=true |